Nanobiotix to Present at H.C. Wainwright 26th Annual Global Investment Conference
Nanobiotix (NASDAQ: NBTX), a late-clinical stage biotechnology company, announced its participation in the H.C. Wainwright 26th Annual Global Investment Conference. The event will feature a fireside chat with company management on Wednesday, September 11, 2024, at 9:30 AM EDT / 3:30 PM CEST in New York, NY.
Presenters include Laurent Levy, co-founder and chairman of the executive board, and Bart Van Rhijn, chief financial officer. The fireside chat will be webcast live from the company's website, with a replay available after the event. Nanobiotix is known for pioneering physics-based approaches to expand treatment possibilities for cancer patients.
Nanobiotix (NASDAQ: NBTX), un'azienda biotecnologica in fase clinica avanzata, ha annunciato la sua partecipazione alla 26ª Conferenza Annuale di Investimenti Globali H.C. Wainwright. L'evento includerà una chiacchierata informale con la direzione dell'azienda il mercoledì 11 settembre 2024, alle 9:30 EDT / 15:30 CEST a New York, NY.
I relatori includeranno Laurent Levy, co-fondatore e presidente del consiglio esecutivo, e Bart Van Rhijn, direttore finanziario. La chiacchierata informale sarà trasmessa in diretta dal sito web dell'azienda, con una replica disponibile dopo l'evento. Nanobiotix è conosciuta per i suoi approcci innovativi basati sulla fisica per ampliare le possibilità di trattamento per i pazienti affetti da cancro.
Nanobiotix (NASDAQ: NBTX), una empresa de biotecnología en fase clínica avanzada, anunció su participación en la 26ª Conferencia Anual de Inversiones Globales H.C. Wainwright. El evento contará con una charla informal con la dirección de la empresa el miércoles 11 de septiembre de 2024, a las 9:30 AM EDT / 3:30 PM CEST en Nueva York, NY.
Los presentadores incluirán a Laurent Levy, cofundador y presidente del consejo ejecutivo, y Bart Van Rhijn, director financiero. La charla informal será transmitida en vivo a través del sitio web de la empresa, con una repetición disponible después del evento. Nanobiotix es conocida por sus enfoques innovadores basados en la física para ampliar las posibilidades de tratamiento para los pacientes con cáncer.
Nanobiotix (NASDAQ: NBTX), 임상 최종 단계의 생명공학 회사는 H.C. Wainwright 제26회 연례 글로벌 투자 회의에 참여한다고 발표했습니다. 이 행사는 2024년 9월 11일 수요일, 오전 9:30 EDT / 오후 3:30 CEST에 뉴욕에서 회사 경영진과의 공개 대화가 진행됩니다.
발표자는 로랑 레비, 공동 창립자이자 집행 위원장, 바르트 반 라이힌, 최고 재무 책임자가 포함됩니다. 이 공개 대화는 회사 웹사이트에서 실시간으로 중계됩니다, 행사 후 재청취할 수 있습니다. Nanobiotix는 암 환자의 치료 가능성을 확장하기 위한 물리학 기반의 접근 방식을 개척한 것으로 알려져 있습니다.
Nanobiotix (NASDAQ: NBTX), une entreprise de biotechnologie en phase clinique avancée, a annoncé sa participation à la 26ème Conférence Annuelle d'Investissement Mondial H.C. Wainwright. L'événement comprendra un entretien informel avec la direction de l'entreprise le mercredi 11 septembre 2024, à 9h30 EDT / 15h30 CEST à New York, NY.
Les présentateurs incluent Laurent Levy, cofondateur et président du conseil d'exécutif, et Bart Van Rhijn, directeur financier. L'entretien sera diffusé en direct sur le site web de l'entreprise, avec une rediffusion disponible après l'événement. Nanobiotix est connue pour ses approches novatrices basées sur la physique pour élargir les possibilités de traitement pour les patients atteints de cancer.
Nanobiotix (NASDAQ: NBTX), ein biotechnologisches Unternehmen in der späten klinischen Phase, kündigte seine Teilnahme an der 26. jährlichen globalen Investorenkonferenz von H.C. Wainwright an. Die Veranstaltung umfasst ein informelles Gespräch mit der Unternehmensleitung am Mittwoch, den 11. September 2024, um 9:30 Uhr EDT / 15:30 Uhr CEST in New York, NY.
Zu den Präsentatoren gehören Laurent Levy, Mitbegründer und Vorsitzender des Exekutivvorstands, sowie Bart Van Rhijn, Finanzvorstand. Das informelle Gespräch wird live über die Unternehmenswebsite übertragen, mit einer Wiederholung, die nach der Veranstaltung verfügbar ist. Nanobiotix ist bekannt für ihre wegweisenden, physikbasierten Ansätze zur Erweiterung der Behandlungsmöglichkeiten für Krebspatienten.
- None.
- None.
PARIS and CAMBRIDGE, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, announced today that Company management will participate in a fireside chat at the upcoming H.C. Wainwright 26th Annual Global Investment conference. Please see below for details of the event.
H.C. Wainwright 26th Annual Global Investment conference
Date: Wednesday, September 11, 2024
Time: 9:30 AM EDT / 3:30 PM CEST
Location: New York, NY
Presenters: Laurent Levy, co-founder of Nanobiotix and chairman of the executive board & Bart Van Rhijn, chief financial officer of Nanobiotix
Webcast link: Click here
The fireside chat will be webcast live from the events page of the Investors section of the Company’s website. Replay of the webcast will be available following the event.
About NANOBIOTIX
Nanobiotix is a late-stage clinical biotechnology company pioneering disruptive, physics-based therapeutic approaches to revolutionize treatment outcomes for millions of patients; supported by people committed to making a difference for humanity. The Company’s philosophy is rooted in the concept of pushing past the boundaries of what is known to expand possibilities for human life.
Incorporated in 2003, Nanobiotix is headquartered in Paris, France and is listed on Euronext Paris since 2012 and on the Nasdaq Global Select Market in New York City since December 2020. The Company has subsidiaries in Cambridge, Massachusetts (United States) amongst other locations.
Nanobiotix is the owner of more than 25 patent families associated with three (3) nanotechnology platforms with applications in 1) oncology; 2) bioavailability and biodistribution; and 3) disorders of the central nervous system.
For more information about Nanobiotix, visit us at www.nanobiotix.com or follow us on LinkedIn and Twitter.
Contacts
| Nanobiotix | ||
| Communications Department Brandon Owens VP, Communications +1 (617) 852-4835 contact@nanobiotix.com | Investor Relations Department Craig West SVP, Investor Relations +1 (617) 583-0211 investors@nanobiotix.com | |
| Media Relations | ||
FR – Ulysse Communication Pierre-Louis Germain + 33 (0) 6 64 79 97 51 plgermain@ulysse-communication.com | Global – LifeSci Advisors Kevin Gardner +1 (617) 283-2856 kgardner@lifesciadvisors.com | |
Attachment
FAQ
When is Nanobiotix (NBTX) presenting at the H.C. Wainwright Global Investment Conference?
Who will be presenting for Nanobiotix (NBTX) at the investment conference?
Where can I watch the Nanobiotix (NBTX) fireside chat from the H.C. Wainwright conference?
What is the focus of Nanobiotix's (NBTX) research?
